Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70362 |
V11294A
|
Others | Others |
V11294A is a novel PDE4 inhibitor. A single oral 300 mg dose of V11294A administered to healthy volunteers results in plasma concentrations adequate to inhibit activation of inflammatory cells ex vivo, which persists for at least 24 h without any adverse reactions |